INTERNATIONAL PATENT: SHANGHAI ALLINK BIOTHERAPEUTICS CO., LTD., 上海安领科生物医药有限公司 FILES APPLICATION FOR "ANTI-EGFR MONOCLONAL ANTIBODY, BISPECIFIC ANTIBODY THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF"

Posted On: 2025-07-08

GENEVA, July 8 -- SHANGHAI ALLINK BIOTHERAPEUTICS CO., LTD. (Room 218, 2nd Floor, Building 2, No. 98 Yunying Road, Lingang Special Zone, Pilot Free Trade ZonePudong New Area, Shanghai 201208), 上海安领科生物医药有限公司 (中国上海市浦东新区中国（上海）自由贸易试验区临港新片区云樱路98号2幢二层218) filed a patent application (PCT/CN2024/143726) for "ANTI-EGFR MONOCLONAL ANTIBODY, BISPECIFIC ANTIBODY THEREOF, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF" on Dec 30, ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SHANGHAI ALLINK BIOTHERAPEUTICS CO., LTD., 上海安领科生物医药有限公司 FILES APPLICATION FOR "ANTI-EGFR MONOCLONAL ANTIBODY, BISPECIFIC ANTIBODY THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF"